First Eagle Investment Management LLC Has $7.68 Million Position in InfuSystem Holdings, Inc. (NYSE:INFU)

First Eagle Investment Management LLC boosted its holdings in shares of InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) by 25.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 908,371 shares of the company's stock after acquiring an additional 186,668 shares during the quarter. First Eagle Investment Management LLC owned 4.27% of InfuSystem worth $7,676,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in INFU. Barclays PLC grew its holdings in InfuSystem by 300.5% during the 3rd quarter. Barclays PLC now owns 28,597 shares of the company's stock worth $192,000 after acquiring an additional 21,457 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in InfuSystem during the 3rd quarter worth approximately $87,000. GSA Capital Partners LLP lifted its position in shares of InfuSystem by 23.9% in the 3rd quarter. GSA Capital Partners LLP now owns 65,680 shares of the company's stock worth $440,000 after purchasing an additional 12,657 shares during the period. Bank of New York Mellon Corp lifted its position in shares of InfuSystem by 14.3% in the 4th quarter. Bank of New York Mellon Corp now owns 91,219 shares of the company's stock worth $771,000 after purchasing an additional 11,436 shares during the period. Finally, Legato Capital Management LLC acquired a new position in shares of InfuSystem in the 4th quarter worth approximately $85,000. 71.13% of the stock is owned by institutional investors.

InfuSystem Trading Down 1.4 %

Shares of NYSE INFU traded down $0.08 during midday trading on Wednesday, reaching $5.72. The stock had a trading volume of 68,367 shares, compared to its average volume of 74,200. The firm has a market cap of $120.17 million, a price-to-earnings ratio of 95.35 and a beta of 1.75. InfuSystem Holdings, Inc. has a twelve month low of $5.29 and a twelve month high of $9.97. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The company's 50 day moving average price is $7.56 and its 200 day moving average price is $7.56.

Remove Ads

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of InfuSystem from a "buy" rating to a "strong-buy" rating in a research report on Friday, March 14th.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.